Fundraising Fox
Vicora
Buffalo, US · Founded 2020 · Delaware corporation
Find your way into Vicora
Sign up to see every warm intro you have to Vicora
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vicora team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vicora develops a thrombectomy catheter with an integrated vibrating distal tip for removing blood clots such as those from deep vein thrombosis and pulmonary embolism. The medical device company is in pre-clinical testing and targets clinicians treating venous thromboembolism.
Founders & leadership
SP
Shawn PattersonExecutive
MC
Matthew ColpoysExecutive
RD
Richard DucharmeExecutive
Board
WM
William MaggioBoard director
Reported raises · per SEC filings
Form D private placements$5.7M disclosed across 2 rounds · 2025–2026
▶$2.3MraisedSep 2026 · 59 investors · BiotechnologyRule 506(b)
▶$2.3MraisedSep 2026 · 59 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew ColpoysExecutive Officer, Director
- Shawn PattersonExecutive Officer
- William MaggioDirector
- Richard DucharmeExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.3M
- Minimum investment
- $25K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedOct 2025 · 55 investors · BiotechnologyRule 506(b)
▶$3.4MraisedOct 2025 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn PattersonExecutive Officer
- William MaggioDirector
- Matthew ColpoysExecutive Officer, Director
- Richard DucharmeExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $3.4M
- Minimum investment
- $25K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
ExploraMed VExploraMed is a medical device incubator that develops new med tech companies and products from early-stage concept through development. Its portfolio includes ventures such as Revelle Aesthetics, an aesthetics medical device company acquired by Tiger Aesthetics in 2024.
Imperative Care IncImperative Care develops medical technologies for treating stroke and other vascular diseases, aiming to address gaps across the patient care journey. The company focuses on devices and solutions for patients suffering from devastating vascular conditions.
Companies working in the same space as Vicora.
Frequently asked questions
- What does Vicora do?
- Vicora develops a thrombectomy catheter with an integrated vibrating distal tip for removing blood clots such as those from deep vein thrombosis and pulmonary embolism. The medical device company is in pre-clinical testing and targets clinicians treating venous thromboembolism.
- How much funding has Vicora raised?
- Vicora has disclosed $5.7M raised across 2 rounds.
- Where is Vicora headquartered?
- Vicora is headquartered in Buffalo, US.